Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Baleseng Nkolobe"'
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
The use of targeted therapeutics known as poly(adenosine diphosphate–ribose) polymerase (PARP) inhibitors in the management of ovarian cancer is currently transforming clinical practice. The PARP inhibitor rucaparib is indicated in the UK, European
Externí odkaz:
https://doaj.org/article/3f63c5cc85b74c81bc129307a9b5a654